Beyond its suppressive immune functions, sHLA-G was considered as a diagnostic tool to distinguish between malignant and benign tumors or health controls, and as a prognostic factor in prediction of the disease outcome [16–18, 29]. Here, HLA-G is linked to benign neoplasm.